SG11201912071QA - Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use - Google Patents

Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use

Info

Publication number
SG11201912071QA
SG11201912071QA SG11201912071QA SG11201912071QA SG11201912071QA SG 11201912071Q A SG11201912071Q A SG 11201912071QA SG 11201912071Q A SG11201912071Q A SG 11201912071QA SG 11201912071Q A SG11201912071Q A SG 11201912071QA SG 11201912071Q A SG11201912071Q A SG 11201912071QA
Authority
SG
Singapore
Prior art keywords
mtsp
polypeptides
methods
serine protease
membrane type
Prior art date
Application number
SG11201912071QA
Inventor
Edwin Madison
Vanessa Soros
Mikhail Popkov
Original Assignee
Catalyst Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalyst Biosciences Inc filed Critical Catalyst Biosciences Inc
Publication of SG11201912071QA publication Critical patent/SG11201912071QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21109—Matriptase (3.4.21.109)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SG11201912071QA 2017-06-22 2018-06-21 Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use SG11201912071QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762523735P 2017-06-22 2017-06-22
US201862664051P 2018-04-27 2018-04-27
PCT/US2018/038844 WO2018237201A1 (en) 2017-06-22 2018-06-21 Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use

Publications (1)

Publication Number Publication Date
SG11201912071QA true SG11201912071QA (en) 2020-01-30

Family

ID=63015005

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201912071QA SG11201912071QA (en) 2017-06-22 2018-06-21 Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
SG10202110492YA SG10202110492YA (en) 2017-06-22 2018-06-21 Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
SG10202110500TA SG10202110500TA (en) 2017-06-22 2018-06-21 Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG10202110492YA SG10202110492YA (en) 2017-06-22 2018-06-21 Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
SG10202110500TA SG10202110500TA (en) 2017-06-22 2018-06-21 Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use

Country Status (18)

Country Link
US (5) US10781435B2 (en)
EP (1) EP3641801A1 (en)
JP (2) JP7091373B2 (en)
KR (1) KR20200030063A (en)
CN (1) CN111107870A (en)
AU (2) AU2018290281B2 (en)
BR (1) BR112019027583A2 (en)
CA (2) CA3067851C (en)
CL (3) CL2019003813A1 (en)
CO (1) CO2020000584A2 (en)
IL (2) IL308949A (en)
JO (1) JOP20190288A1 (en)
MX (1) MX2019015402A (en)
NZ (1) NZ760116A (en)
PE (1) PE20200697A1 (en)
PH (1) PH12019502838A1 (en)
SG (3) SG11201912071QA (en)
WO (1) WO2018237201A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
WO2015105955A1 (en) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
CA3085784A1 (en) 2017-12-14 2019-06-20 Flodesign Sonics, Inc. Acoustic transducer driver and controller
US11396529B2 (en) * 2020-11-12 2022-07-26 National Sun Yat-Sen University Isolated peptide, anti-cancer medicinal composition including the same and method of specifically reducing or inhibiting activities of cancer cells using the same
KR20230142496A (en) * 2021-01-08 2023-10-11 버텍스 파마슈티칼스 인코포레이티드 factor B protease
CN113456527B (en) * 2021-07-30 2023-04-07 北京清大赛尔生物科技有限公司 NADH microcapsule preparation and preparation method and application thereof

Family Cites Families (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324A (en) 1847-10-09 Cooking-stove
US5990A (en) 1848-12-26 of baltimore
US569A (en) 1838-01-09 Caruiag-e-spiiln g
US5795A (en) 1848-09-19 Saddletree for carts
US237A (en) 1837-06-15 Egbert beale
US844A (en) 1838-07-17 Boiler for
GB1429184A (en) 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4002531A (en) 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4952496A (en) 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
DE3921528A1 (en) 1989-06-30 1991-01-10 Draegerwerk Ag MEASURING CELL FOR ELECTROCHEMICAL GAS DETECTION
US5256643A (en) 1990-05-29 1993-10-26 The Government Of The United States Human cripto protein
US5262522A (en) 1991-11-22 1993-11-16 Immunex Corporation Receptor for oncostatin M and leukemia inhibitory factor
AU7097094A (en) 1993-06-01 1994-12-20 Enzon, Inc. Carbohydrate-modified polymer conjugates with erythropoietic activity
US5457035A (en) 1993-07-23 1995-10-10 Immunex Corporation Cytokine which is a ligand for OX40
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US5795569A (en) 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
WO1995026746A1 (en) 1994-03-31 1995-10-12 Amgen Inc. Compositions and methods for stimulating megakaryocyte growth and differentiation
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US6214966B1 (en) 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
US6258351B1 (en) 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
US5990237A (en) 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
US6448369B1 (en) 1997-11-06 2002-09-10 Shearwater Corporation Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
US5985263A (en) 1997-12-19 1999-11-16 Enzon, Inc. Substantially pure histidine-linked protein polymer conjugates
EP1061954B1 (en) 1998-03-12 2004-06-09 Nektar Therapeutics Al, Corporation Poly(ethylene glycol) derivatives with proximal reactive groups
EP1095243A2 (en) 1998-07-03 2001-05-02 Neles Field Controls Oy Method and arrangement for measuring fluid
US6153394A (en) 1998-09-18 2000-11-28 Board Of Trustees Operating Michigan State University Immunoassay for equine protozoal myeloencephalitis in horses
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
JP2003514765A (en) 1999-02-28 2003-04-22 ワシントン ユニバーシティー Novel transducing molecules and methods of use
CA2362670A1 (en) 1999-03-12 2000-09-14 Georgetown University Matriptase, a serine protease and its applications
CZ299516B6 (en) 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Erythropoietin glycoprotein conjugate, process for its preparation and use and pharmaceutical composition containing thereof
JO2291B1 (en) 1999-07-02 2005-09-12 اف . هوفمان لاروش ايه جي Erythopintin derivatives
US6461802B1 (en) 1999-08-02 2002-10-08 Agfa-Gevaert Adhesive layer for polyester film
US7030231B1 (en) 1999-09-30 2006-04-18 Catalyst Biosciences, Inc. Membrane type serine protease 1 (MT-SP1) and uses thereof
AU1436401A (en) 1999-10-21 2001-05-14 Board Of Trustees Of The University Of Arkansas, The RepO-associated virus AAV REP78 major regulatory protein, mutants thereof and uses thereof
DK1259562T3 (en) 1999-12-22 2006-04-18 Nektar Therapeutics Al Corp Sterically hindered derivatives of water-soluble polymers
US6413507B1 (en) 1999-12-23 2002-07-02 Shearwater Corporation Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
US7700341B2 (en) 2000-02-03 2010-04-20 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
WO2001062827A2 (en) 2000-02-22 2001-08-30 Shearwater Corporation N-maleimidyl polymer derivatives
ATE367398T1 (en) 2000-05-16 2007-08-15 Bolder Biotechnology Inc METHOD FOR REFOLDING PROTEINS WITH FREE CYSTEINE RESIDUE
GB0103110D0 (en) 2000-08-25 2001-03-28 Aventis Pharma Inc A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1
US7157596B2 (en) 2000-09-08 2007-01-02 Dendreon Corporation Inhibitors of serine protease activity of matriptase or MTSP1
EP1345628B1 (en) 2000-12-20 2011-04-13 F. Hoffmann-La Roche AG Conjugates of erythropoietin (epo) with polyethylene glycol (peg)
TWI246524B (en) 2001-01-19 2006-01-01 Shearwater Corp Multi-arm block copolymers as drug delivery vehicles
AU2002305052A1 (en) 2001-03-13 2002-09-24 Corvas International, Inc. Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
EP1379637A4 (en) 2001-03-27 2005-04-06 Dendreon Corp Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
JP2005506832A (en) 2001-05-14 2005-03-10 デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー Nucleic acid molecule encoding transmembrane serine protease 10, encoded polypeptide and method based thereon
JP2005518332A (en) 2001-05-23 2005-06-23 デンドレオン コーポレイション Conjugates activated by cell surface proteases and their therapeutic use
US6908963B2 (en) 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
AU2002356824A1 (en) 2001-10-19 2003-05-06 The Scripps Research Institute Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
JP4758608B2 (en) 2001-11-07 2011-08-31 ネクター セラピューティックス Branched polymers and their conjugates
US8188231B2 (en) 2002-09-27 2012-05-29 Xencor, Inc. Optimized FC variants
US7192468B2 (en) 2002-04-15 2007-03-20 Fluor Technologies Corporation Configurations and method for improved gas removal
WO2003104394A2 (en) 2002-05-21 2003-12-18 Dendreon San Diego Llc Nucleic acid molecules encoding a transmembrane serine protease 12, the encoded polypeptides and methods based thereon
KR20100109969A (en) 2002-10-02 2010-10-11 카탈리스트 바이오사이언시즈, 인코포레이티드 Methods of generating and screening for proteases with altered specificity
US20060024289A1 (en) 2002-10-02 2006-02-02 Ruggles Sandra W Cleavage of VEGF and VEGF receptor by wild-type and mutant proteases
US7939304B2 (en) * 2002-10-02 2011-05-10 Catalyst Biosciences, Inc. Mutant MT-SP1 proteases with altered substrate specificity or activity
KR20040040782A (en) 2002-11-08 2004-05-13 선바이오(주) Novel hexa-arm polyethylene glycol and its derivatives and the methods of preparation thereof
AU2003299818A1 (en) 2002-12-20 2004-07-22 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US7019019B2 (en) 2002-12-23 2006-03-28 Dendreon Corporation Matriptase inhibitors and methods of use
US20040147027A1 (en) 2003-01-28 2004-07-29 Troy Carol M. Complex for facilitating delivery of dsRNA into a cell and uses thereof
US20060178297A1 (en) 2003-01-28 2006-08-10 Troy Carol M Systems and methods for silencing expression of a gene in a cell and uses thereof
EP2572732A1 (en) 2003-02-26 2013-03-27 Nektar Therapeutics Polymer-factor VIII moiety conjugates
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
KR100512483B1 (en) 2003-05-07 2005-09-05 선바이오(주) Novel Preparation method of PEG-maleimide PEG derivatives
NZ541374A (en) 2003-05-23 2008-09-26 Nektar Therapeutics Al Corp PEG derivatives having an amidocarbonate linkage
US7595306B2 (en) 2003-06-09 2009-09-29 Alnylam Pharmaceuticals Inc Method of treating neurodegenerative disease
AU2004316996A1 (en) 2003-06-20 2005-09-15 The Regents Of The University Of California Polypeptide transduction and fusogenic peptides
US7439226B2 (en) 2003-09-30 2008-10-21 The United States Of America As Represented By The Department Of Health And Human Services Serine protease inhibitors
EP2275448A3 (en) 2003-12-19 2013-02-06 Genentech, Inc. Monovalent antibody fragments useful as therapeutics
CA2562729C (en) 2004-04-12 2013-11-12 Sandra Waugh Ruggles Cleavage of vegf and vegf receptor by wildtype and mutant mt-sp1
US8173144B2 (en) 2004-11-04 2012-05-08 L'oreal Administration of urea compounds for combating signs of cutaneous aging
EP1851543A2 (en) 2005-02-24 2007-11-07 Compugen Ltd. Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
CA2626356C (en) 2005-10-21 2017-08-22 Catalyst Biosciences, Inc. Modified proteases that inhibit complement activation
AU2011218753B2 (en) * 2005-10-21 2013-10-24 Vertex Pharmaceuticals Incorporated Modified proteases that inhibit complement activation
JP2009513158A (en) 2005-11-01 2009-04-02 アリゾナ ボード オブ リージェンツ ア ボディー コーポレート アクティング オン ビハーフ オブ アリゾナ ステイト ユニバーシティ Novel protein transduction domains and uses thereof
US7579318B2 (en) 2005-12-06 2009-08-25 Centre De La Recherche De La Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2007097561A1 (en) 2006-02-20 2007-08-30 Ewha University - Industry Collaboration Foundation Peptide having cell membrane penetrating activity
EP1867661A1 (en) 2006-06-12 2007-12-19 Diatos Compositions and methods for delivering anti-activated ras antibodies into cells
CN107630011A (en) * 2006-07-05 2018-01-26 催化剂生物科学公司 Protease screening procedure and the protease thus differentiated
JP4546578B2 (en) 2006-07-05 2010-09-15 カタリスト・バイオサイエンシーズ・インコーポレイテッド Protease screening method and protease identified thereby
CA2761310C (en) 2009-05-07 2017-02-28 Charles S. Craik Antibodies and methods of use thereof
WO2012021891A2 (en) 2010-08-13 2012-02-16 Tufts University Compositions, kits and methods for treatment of complement-related disorders
CA2843631A1 (en) 2011-10-14 2013-04-18 Alain Moreau Methods and kits for diagnosing and/or prognosing osteoarthritis
AU2013207900B2 (en) 2012-01-12 2017-12-07 Cambridge Enterprise Limited Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase
EP2833923A4 (en) 2012-04-02 2016-02-24 Moderna Therapeutics Inc Modified polynucleotides for the production of proteins
US10029415B2 (en) 2012-08-16 2018-07-24 Stratasys, Inc. Print head nozzle for use with additive manufacturing system
CA2836167A1 (en) 2013-12-10 2015-06-10 Christina Xiaolin Dai Thickness increase spring
DK3137595T3 (en) * 2014-04-29 2019-06-17 Novartis Ag New vertebrate cells and methods for recombinant expression of a polypeptide of interest
TWI702228B (en) 2014-08-08 2020-08-21 美商Ａｌｘ腫瘤技術股份有限公司 Sirp-alpha variant constructs and uses thereof
EP3733696A1 (en) 2015-01-13 2020-11-04 City of Hope Ctla4-binding protein peptide-linker masks
KR20220029783A (en) 2015-01-20 2022-03-08 아비나스 오퍼레이션스, 인코포레이티드 Compounds and Methods for the Targeted Degradation of the Androgen Receptor
AU2016289480C1 (en) 2015-07-06 2021-10-21 Regeneron Pharmaceuticals, Inc. Multispecific antigen-binding molecules and uses thereof
US11903996B2 (en) 2015-10-07 2024-02-20 David C. Fritzinger Modulators of complement function
US9938264B2 (en) 2015-11-02 2018-04-10 Yale University Proteolysis targeting chimera compounds and methods of preparing and using same
CA3176021A1 (en) 2018-12-28 2020-07-02 Catalyst Biosciences, Inc. Modified urokinase-type plasminogen activator polypeptides and methods of use

Also Published As

Publication number Publication date
US20200291376A1 (en) 2020-09-17
US11401513B2 (en) 2022-08-02
BR112019027583A2 (en) 2020-10-06
JP2020528742A (en) 2020-10-01
EP3641801A1 (en) 2020-04-29
WO2018237201A1 (en) 2018-12-27
IL271587A (en) 2020-02-27
JOP20190288A1 (en) 2019-12-16
AU2022201445B2 (en) 2023-11-23
CL2021003080A1 (en) 2022-08-12
CA3177086A1 (en) 2018-12-27
US20210355474A1 (en) 2021-11-18
MX2019015402A (en) 2020-07-20
US10954501B2 (en) 2021-03-23
IL308949A (en) 2024-01-01
IL271587B1 (en) 2024-01-01
AU2022201445A1 (en) 2022-03-24
US11807882B2 (en) 2023-11-07
US20190093097A1 (en) 2019-03-28
US10781435B2 (en) 2020-09-22
US20240018502A1 (en) 2024-01-18
PE20200697A1 (en) 2020-06-16
JP7091373B2 (en) 2022-06-27
JP2022120155A (en) 2022-08-17
CL2019003813A1 (en) 2020-05-29
CA3067851A1 (en) 2018-12-27
PH12019502838A1 (en) 2020-09-21
SG10202110500TA (en) 2021-11-29
CL2021003081A1 (en) 2022-08-12
US20210032617A1 (en) 2021-02-04
AU2018290281A1 (en) 2020-01-30
CO2020000584A2 (en) 2020-05-05
CA3067851C (en) 2023-01-31
SG10202110492YA (en) 2021-11-29
KR20200030063A (en) 2020-03-19
NZ760116A (en) 2024-03-22
CN111107870A (en) 2020-05-05
AU2018290281B2 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
IL271587A (en) Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
HK1247131A1 (en) Matrix metalloprotease-cleavable and serine protease cleavable substrates and methods of use thereof
EP3538561A4 (en) Variant rna-guided polypeptides and methods of use
IL264590A (en) Fc region containing polypeptides and uses thereof
EP3504245A4 (en) Proteolytically cleavable chimeric polypeptides and methods of use thereof
ZA201903984B (en) Methods of using thermostable serine proteases
IL272332A (en) Antigen-presenting polypeptides and methods of use thereof
DK3280432T3 (en) POLYPEPTIDES CONTAINING THE NOVO BINING DOMAINS AND USES THEREOF
IL262802A (en) Glucagon-receptor selective polypeptides and methods of use thereof
EP3509615A4 (en) Stable peptides and methods of use thereof
IL262727A (en) Cd40l-fc fusion polypeptides and methods of use thereof
IL258928A (en) Novel polypeptides with improved proteolytic stability, and methods of preparing and using same
RS64556B1 (en) Novel polypeptides and medical uses thereof
IL290414A (en) Atf5 peptide variants and uses thereof
IL282362A (en) Intein proteins and uses thereof
EP3448991A4 (en) Thermostable protease and methods of making and using the same
IL280808A (en) Ox40-binding polypeptides and uses thereof
EP3504747C0 (en) Membrane electrode assembly and method of making the same
EP3407871A4 (en) Alk polypeptides and methods of use thereof
GB201819200D0 (en) Polypeptide and uses thereof
ZA201805811B (en) Hypersensitive response elicitor-derived peptides and use thereof
MX2019010815A (en) Trypsin-like serine proteases and uses thereof cross-reference to related application.
EP3425054C0 (en) Mutant cytochrome protein and use thereof
PT3526244T (en) Peptides derived from the propeptide ntsr3 and their use in the treatment of depression
HUP1700012A2 (en) Novel proteins and use thereof